SPDL1 and neoplasm: Moreover, a recent study demonstrated that the small molecule inhibitors CH-4 and its analogue CH-4.7 could effectively inhibit the PD-1/sPD-L1 interaction, thereby enhancing anti-tumor immunity in the T cell acute lymphoblastic leukemia model [171].